Cargando…
Sprouty2—a Novel Therapeutic Target in the Nervous System?
Clinical trials applying growth factors to alleviate symptoms of patients with neurological disorders have largely been unsuccessful in the past. As an alternative approach, growth factor receptors or components of their signal transduction machinery may be targeted directly. In recent years, the se...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505497/ https://www.ncbi.nlm.nih.gov/pubmed/30225774 http://dx.doi.org/10.1007/s12035-018-1338-8 |